Skip to main content
Veterinary Medicines

Vetoryl 30 mg hard capsules

Authorised
  • Trilostane

Product identification

Medicine name:
Vetoryl 30 mg hard capsules
Vetoryl 30 mg Kapsel, hård
Active substance:
  • Trilostane
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Trilostane
    30.00
    milligram(s)
    /
    1.00
    Capsule
Pharmaceutical form:
  • Capsule, hard
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02CA01
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:
  • PVC-PVdc / aluminium foil blister packs containing 10 capsules. Each carton contains 3 blister strips.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 22818
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0514/002
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 4/02/2025

Summary of Product Characteristics

English (PDF)
Published on: 23/08/2024
Download
Swedish (PDF)
Published on: 4/02/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 4/02/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."